Ethical AI in Pharma: How Novartis Leads in Data Privacy I Franziska Janorschke, Head of Data Privacy at Novartis

A must-listen for anyone interested in the intersection of technology, healthcare, and ethics, this episode of The Influencers features Franziska Janorschke, Head of Data Privacy at Novartis, discussing the pharmaceutical giant's approach to digital transformation, AI, and data governance with Hogan Lovells host Leo von Gerlach. They explore Novartis' proactive stance on AI compliance, the challenges of AI implementation in complex fields like clinical trials, and how privacy and governance frameworks provide a foundation for responsible innovation.   About Novartis:  Novartis is an innovative medicines company whose medicines reach more than 250 million people worldwide and that works to reimagine medicine to improve and extend people’s lives.   About Hogan Lovells: Our Digital Transformation offering helps clients navigate the full breadth and depth of the seismic forces impacting their organizations – and today’s society. Leveraging team members across our 2800 lawyers on six continents, we provide integrated advice on the multifaceted regulatory, governance and enforcement issues and risks that arise across the many technologies and trends that comprise the new digital future. If you enjoyed today's episode, we'd love for you to rate and review us. Your feedback helps us reach more listeners and continue bringing insightful conversations on digital transformation and law. Thank you for your support!